SNDX
NASDAQ · Biotechnology
Syndax Pharmaceuticals Inc
$19.11
-2.32 (-10.83%)
Open$20.83
Previous Close$21.43
Day High$21.22
Day Low$19.00
52W High$25.59
52W Low$8.58
Volume—
Avg Volume1.99M
Market Cap1.91B
P/E Ratio—
EPS$-3.30
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+28.2% upside
Current
$19.11
$19.11
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 199.04M | 42.66M | 332.47M |
| Net Income | -329,621,278 | -516,701,989 | -96,723,913 |
| Profit Margin | -165.6% | -1,278.8% | -29.1% |
| EBITDA | -316,846,190 | -581,608,963 | -125,567,751 |
| Free Cash Flow | — | — | -63,645,585 |
| Rev Growth | — | -44.7% | -3.0% |
| Debt/Equity | 5.32 | 1.19 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |